Evommune, Inc.·4

Nov 7, 4:15 PM ET

Pena Luis C. 4

4 · Evommune, Inc. · Filed Nov 7, 2025

Insider Transaction Report

Form 4
Period: 2025-11-05
Pena Luis C.
DirectorPresident & CEO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-11-05+796,841796,841 total
    Exercise: $16.00Exp: 2035-11-04Common Stock (796,841 underlying)
Footnotes (1)
  • [F1]One fourth (1/4) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file
  • 4
    form4-11072025_041102.xmlPrimary